Mark Cunningham

Head of Operations, NATA - Nucleic Acid Therapy Accelerator

Just started a new chapter in my career as Head of Operations at the Nucleic Acid Therapy Accelerator (NATA), part of the UK MRC and UKRI. At NATA we are looking to develop internal capabilities and partner with external scientists in the fields of oligonucleotide chemistry and biology. Previously, at Janssen R&D, I played a variety of roles including ‘Chief of Staff’ for the Immunology Therapeutic Area, ‘Scientific Strategist’ evolving R&D facilities in Philadelphia, PA and San Francisco, CA and ‘Governance Facilitator’ for projects in Early and Late Development phases focused on autoimmune diseases. I want to do a job that I love by taking advantage of my scientific education, R&D experience (in both small and large molecule programs) and by joining a team that enables the development of new healthcare solutions for patients with unmet medical need. The picture is my son sculling on the Schuylkill river, returning to Boathouse Row on a warm summer’s evening in 2018.

21 September 2023, GLASGOW

Stevenage Bioscience Catalyst

30 November 2023